Concert Pharmaceuticals Price on February 15, 2023
CNCEDelisted Stock | USD 8.37 0.01 0.12% |
If you're considering investing in Concert Stock, it is important to understand the factors that can impact its price. As of today, the current price of Concert Pharmaceuticals stands at 8.37, as last reported on the 29th of November, with the highest price reaching 8.55 and the lowest price hitting 8.35 during the day. We have found thirty technical indicators for Concert Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Concert Pharmaceuticals' Downside Deviation of 2.74, mean deviation of 2.79, and Risk Adjusted Performance of 0.1565 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Concert Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Concert |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CNCE |
Based on monthly moving average Concert Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Concert Pharmaceuticals by adding Concert Pharmaceuticals to a well-diversified portfolio.
Concert Pharmaceuticals Main Headline on 15th of February 2023
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates CNCE... by hawaiinewsnow.com
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates CNCE, ISO, TIG Published Feb. 15, 2023 at 605 AM HST Updated 8 minutes ago NEW YORK , Feb. 15, 2023 PRNewswire -- Halper Sadeh LLC, an investor rights law firm, is investigating the foll
Concert Pharmaceuticals Valuation on February 15, 2023
It is possible to determine the worth of Concert Pharmaceuticals on a given historical date. On February 15, 2023 Concert was worth 8.36 at the beginning of the trading date compared to the closed value of 8.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Concert Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Concert Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Concert Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Concert Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
8.33 | 8.36 | 8.32 | 8.34 | 1,418,184 | |
02/15/2023 | 8.36 | 8.36 | 8.33 | 8.35 | 1,186,808 |
8.35 | 8.41 | 8.35 | 8.38 | 1,499,086 |
Backtest Concert Pharmaceuticals | | | Concert Pharmaceuticals History | | | Concert Pharmaceuticals Valuation | Previous | Next |
Concert Pharmaceuticals Trading Date Momentum on February 15, 2023
On February 16 2023 Concert Pharmaceuticals was traded for 8.38 at the closing time. The top price for the day was 8.41 and the lowest listed price was 8.35 . The trading volume for the day was 1.5 M. The trading history from February 16, 2023 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 0.36% . The overall trading delta against the current closing price is 0.48% . |
Concert Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Concert Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Concert Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Concert financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Concert Pharmaceuticals Stock history
Concert Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Concert is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Concert Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Concert Pharmaceuticals stock prices may prove useful in developing a viable investing in Concert Pharmaceuticals
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. Concert Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 64 people.
Concert Pharmaceuticals Stock Technical Analysis
Concert Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Concert Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Concert Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Concert Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Concert Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Concert Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Concert Pharmaceuticals stock market strength indicators, traders can identify Concert Pharmaceuticals entry and exit signals to maximize returns
Concert Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Concert Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Concert Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Concert to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1565 | |||
Jensen Alpha | 0.7094 | |||
Total Risk Alpha | 0.1855 | |||
Sortino Ratio | 0.2761 | |||
Treynor Ratio | 0.6173 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Concert Stock
If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Transaction History View history of all your transactions and understand their impact on performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |